Selective, reversible, ATP-competitive inhibitor of protein kinase C. Inhibits PKCalpha, beta1, beta2, gamma and epsilon, IC50= 8, 8, 14,13 and 39 nM respectively.1 Extremely useful tool for probing PKC-dependent physiology2 or signaling pathways3. Increases MSC adhesion to an ICAM-1 coated substrate in vitro and enables targeted delivery of systematically administered MSCs to inflamed sites in vivo in a CD11a-dependent manner.4 Cell permeable.
* VAT and and shipping costs not included. Errors and price changes excepted